post hoc analysis: phase 3 asclepios i and ii trials in relapsing ms
Published 4 years ago • 241 plays • Length 4:56Download video MP4
Download video MP3
Similar videos
-
3:35
post hoc analysis: phase 3 expand trial in secondary progressive ms
-
2:54
open-label extension: phase 3 opera i and ii trials in relapsing ms
-
4:41
ofatumumab for relapsing ms
-
14:13
efficacy & safety of ofatumumab vs teriflunomide in relapsing ms: phase 3 asclepios i&ii trials
-
3:26
phase iii ultimate i & ii update: ublituximab versus teriflunomide in relapsing ms
-
1:55
day 21 of kesimpta
-
4:38
briumvi for multiple sclerosis | effectiveness | side effects
-
11:38
my unusual multiple sclerosis symptoms / living 3 years with with relapsing ms - catch up
-
5:46
siponimod for relapsing ms
-
2:26
jeffrey cohen, md: the success of ofatumumab in relapsing ms
-
3:41
stephen l. hauser, md: ofatumumab in treatment-naïve patients with ms
-
3:27
ultimate i & ii results: ublituximab versus teriflunomide in relapsing ms
-
3:43
aan 2020 data release: ofatumumab for relapsing ms
-
2:07
jeffrey cohen, md: ofatumumab’s potential role in ms care
-
5:14
role of ozanimod in multiple sclerosis
-
6:07
goals of therapy for relapsing ms
-
4:23
recent treatment strategies explored for relapsing ms
-
6:01
ocrelizumab for relapsing ms
-
![kesimpta (ofatumumab) for multiple sclerosis [asclepios i/ii trial results]](https://i.ytimg.com/vi/IIBBlvnPjS0/mqdefault.jpg)
14:03
kesimpta (ofatumumab) for multiple sclerosis [asclepios i/ii trial results]
-
2:20
phase iii trials of tolebrutinib in relapsing-remitting and progressive ms
-
2:21
retinal structure and function correlation in ms